0001127602-17-022461.txt : 20170630
0001127602-17-022461.hdr.sgml : 20170630
20170630162244
ACCESSION NUMBER: 0001127602-17-022461
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170628
FILED AS OF DATE: 20170630
DATE AS OF CHANGE: 20170630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SULLIVAN LOUIS W
CENTRAL INDEX KEY: 0001193522
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 17942459
FORMER NAME:
FORMER CONFORMED NAME: SULLIVAN LOUIS
DATE OF NAME CHANGE: 20020927
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-06-28
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001193522
SULLIVAN LOUIS W
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
Restricted Stock Units
0
2017-06-28
4
A
0
1620
0
A
Common Stock
1620
1620
D
Stock Options
132.30
2017-06-28
4
A
0
4210
0
A
2018-06-28
2027-06-28
Common Stock
4210
4210
D
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
Annual non-employee director grant of restricted stock units and/or stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders.
The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares.
Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.
/s/ John S. Hess, Jr. under Power of Attorney
2017-06-30